Biomarker Discovery
The NeoVentures invention of reproducible aptamer selection with the Neomer platform enables a novel and powerful application for biomarker discovery for any disease or condition. For the first time it is possible to screen the same library of aptamers for their selection response to biological fluids or tissue from individuals that differ in their medical condition. With the Aptamarker platform we harness this power to screen for quantitative differences in 4.29E9 potential epitopes per sample. This is an unprecedented step forward in magnitude for agnostic identification of molecular differences as they relate to any characterized phenotype.